Figure 2

Survival by whole-brain radiotherapy prior to or concurrent with chemotherapy in non-small-cell lung cancer patients who were EGFR, ALK, and PD-L1 negative, had an ECOG PS of 2, and had multiple metastases including brain metastases. (A) Intracranial progression-free survival. (B) Overall survival.